SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MabCure, Inc. Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents